HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function.

Abstract
Oestrogen receptor alpha (ERalpha) is an oestrogen-activated transcription factor, which regulates proliferation and differentiation of mammary epithelial cells by activating or repressing gene expression. ERalpha is a critical prognostic indicator and a therapeutic target for breast cancer. Patients with tumours that express higher level of ERalpha have better prognosis than patients with tumours that are ERalpha negative or express lower level of ERalpha. Better prognosis in ERalpha-positive patients is believed to be due to repression of proinvasive gene expression by ERalpha. Oestrogen receptor alpha represses gene expression by transrepressing the activity of the transcription factors such as nuclear factor-kappaB or by inducing the expression of transcriptional suppressors such as MTA3. In this report, we show that ERalpha transrepresses the expression of the proinvasive gene interleukin 6 (IL-6) in ERalpha-negative MDA-MB-231 breast cancer cells stably overexpressing ERalpha. Using these cells as well as ERalpha-positive MCF-7 and ZR-75-1 cells, we show that tumour necrosis factor alpha (TNFalpha) and the phosphatidylinositol-3-kinase (PI3-kinase) modulate transrepression function of ERalpha by reducing its stability. From these results, we propose that TNFalpha expression or PI3-kinase activation lead to reduced levels of ERalpha protein in cancer cells and corresponding loss of transrepression function and acquisition of an invasive phenotype.
AuthorsP Bhat-Nakshatri, R A Campbell, N M Patel, T R Newton, A J King, M S Marshall, S Ali, H Nakshatri
JournalBritish journal of cancer (Br J Cancer) Vol. 90 Issue 4 Pg. 853-9 (Feb 23 2004) ISSN: 0007-0920 [Print] England
PMID14970864 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Estrogen Receptor alpha
  • Interleukin-6
  • Receptors, Estrogen
  • Tumor Necrosis Factor-alpha
  • Phosphatidylinositol 3-Kinases
Topics
  • Blotting, Northern
  • Blotting, Western
  • Breast Neoplasms (genetics, pathology)
  • Estrogen Receptor alpha
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Interleukin-6 (biosynthesis, pharmacology)
  • Neoplasm Invasiveness
  • Phenotype
  • Phosphatidylinositol 3-Kinases (pharmacology)
  • Receptors, Estrogen (biosynthesis, physiology)
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: